Back to Search Start Over

Protocol for the New Medicine Service study: a randomized controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicine Service in community pharmacies in England

Authors :
Boyd, Matthew
Waring, Justin
Barber, Nick
Mehta, Rajnikant
Chuter, Antony
Avery, Anthony
Salema, Nde-Eshimuni
Davies, James
Latif, Asam
Tanajewski, Lukasz
Elliott, Rachel A.
Boyd, Matthew
Waring, Justin
Barber, Nick
Mehta, Rajnikant
Chuter, Antony
Avery, Anthony
Salema, Nde-Eshimuni
Davies, James
Latif, Asam
Tanajewski, Lukasz
Elliott, Rachel A.

Abstract

Background Medication non-adherence is considered an important cause of morbidity and mortality in primary care. This study aims to determine the effectiveness, cost effectiveness and acceptability of a complex intervention delivered by community pharmacists, the New Medicine Service (NMS), compared with current practice in reducing non-adherence to, and problems with, newly prescribed medicines for chronic conditions. Methods/design Research subject group: patients aged 14 years and above presenting in a community pharmacy for a newly prescribed medicine for asthma/chronic obstructive pulmonary disease (COPD); hypertension; type 2 diabetes or anticoagulant/antiplatelet agents in two geographical regions in England. Design: parallel group patient-level pragmatic randomized controlled trial. Interventions: patients randomized to either: (i) current practice; or (ii) NMS intervention comprising pharmacist-delivered support for a newly prescribed medicine. Primary outcomes: proportion of adherent patients at six, ten and 26 weeks from the date of presenting their prescriptions at the pharmacy; cost effectiveness of the intervention versus current practice at 10 weeks and 26 weeks; in-depth qualitative understanding of the operationalization of NMS in pharmacies. Secondary outcomes: impact of NMS on: patients’ understanding of their medicines, pharmacovigilance, interprofessional and patient-professional relationships and experiences of service users and stakeholders. Economic analysis: Trial-based economic analysis (cost per extra adherent patient) and long-term modeling of costs and health effects (cost per quality-adjusted-life-year) will be conducted from the perspective of National Health Service (NHS) England, comparing NMS with current practice. Qualitative analysis: a qualitative study of NMS implementation in different community settings, how organizational influences affect NMS delivery, patterns of NMS consultations and experiences of professionals and patien

Details

Database :
OAIster
Notes :
doi:10.1186/1745-6215-14-411
Publication Type :
Electronic Resource
Accession number :
edsoai.on1312864862
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1186.1745-6215-14-411